ESG Inc. financial data

Symbol
ESGH on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
523 School House Rd, Kennett Square, PA
State of incorporation
NV
Fiscal year end
December 31
Former names
PLASMA INNOVATIVE INC. (to 11/13/2023)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 23.3 % +70.5%
Quick Ratio 12.4 %
Debt-to-equity 158 %
Return On Equity -6.32 % -1651%
Return On Assets -2.91 % -329%
Operating Margin -6.95 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9M shares +67.5%
Common Stock, Shares, Outstanding 25.9M shares +67.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 25.9K USD +67.5%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 25.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.62M USD +331%
Cost of Revenue 7.47M USD +1594%
Research and Development Expense 557K USD -5.4%
General and Administrative Expense 1.18M USD +33.4%
Operating Income (Loss) -599K USD -601%
Nonoperating Income (Expense) -245K USD -101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.05M USD -2962%
Net Income (Loss) Attributable to Parent -768K USD -1513%
Earnings Per Share, Basic -0.02 USD/shares
Earnings Per Share, Diluted -0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 445K USD +6798%
Inventory, Net 1.87M USD
Assets, Current 3.73M USD +7938%
Property, Plant and Equipment, Net 769 USD -25.3%
Assets 27.1M USD +57360%
Accounts Payable, Current 2.73M USD +173%
Liabilities, Current 13.7M USD
Liabilities 15M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -436K USD
Retained Earnings (Accumulated Deficit) -1.71M USD -1718%
Stockholders' Equity Attributable to Parent 9.03M USD +19447%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 12.1M USD -5.33%
Liabilities and Equity 27.1M USD +57360%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 95K USD -80.9%
Net Cash Provided by (Used in) Financing Activities 138K USD
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 25.9M shares +67.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 491K USD +37.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 445K USD +169%
Interest Paid, Excluding Capitalized Interest, Operating Activities 150K USD +5.58%
Deferred Tax Assets, Valuation Allowance 2.91M USD +14629%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 1.7M USD +37.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747K USD -653%
Property, Plant and Equipment, Gross 25.6M USD
Deferred Income Tax Expense (Benefit) -174K USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 2.91M USD +14629%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.2M USD +8843%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 68.7K USD +3.95%
Depreciation, Depletion and Amortization 453K USD -3.87%
Interest Expense 125K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%